2013
DOI: 10.1080/08998280.2013.11929011
|View full text |Cite
|
Sign up to set email alerts
|

Copper Deficiency (Hypocupremia) and Pancytopenia Late After Gastric Bypass Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
18
0
3

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(23 citation statements)
references
References 16 publications
(20 reference statements)
2
18
0
3
Order By: Relevance
“…Such patients presented with hematological or neurological symptoms, usually many years after the operations (5-21 years). In those cases, copper supplementation proved effective against anemia and neutropenia, which resolved, but neurological symptoms did not usually show full recovery [26,27] . Awareness of the risk of copper deficiency over the long term after non-bariatric gastrectomy is therefore crucial.…”
Section: Discussionmentioning
confidence: 99%
“…Such patients presented with hematological or neurological symptoms, usually many years after the operations (5-21 years). In those cases, copper supplementation proved effective against anemia and neutropenia, which resolved, but neurological symptoms did not usually show full recovery [26,27] . Awareness of the risk of copper deficiency over the long term after non-bariatric gastrectomy is therefore crucial.…”
Section: Discussionmentioning
confidence: 99%
“…Balsa et al 114 reported that 50.6% of 89 BPD patients had a low serum copper level at least once during a 5‐year period. In addition, numerous case reports have mentioned copper deficiency after RYGB 115 125 . Gletsu‐Miller et al 115 reported a 9.6% prevalence of copper deficiency in 136 RYGB patients.…”
Section: Vitamin and Mineral Supplementation And Potential Deficienciesmentioning
confidence: 99%
“…32 The complications of human copper deficiency such as anemia, pancytopenia, and ataxia are common following bypass surgery. 33 It is critical to detect deficiency before the neurological phenotype is expressed, because treatment often does not help. The goal, therefore, is to develop good sensitive biomarkers of copper status so deficiency can be treated.…”
Section: Copper Biomarkersmentioning
confidence: 99%